article thumbnail

DEA Extends COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for 6 Months

HIT Consultant

For any practitioner-patient telemedicine relationships that have been or will be established up to November 11, 2023, the full set of telemedicine flexibilities regarding the prescription of controlled medications established during the COVID-19 PHE will be extended for one year – through November 11, 2024.

article thumbnail

Tele-Prescribing Flexibilities Extended Again in Second Temporary Rule

Healthcare Law Blog

Under the Second Temporary Rule, practitioners may continue to prescribe schedule II-V controlled medications via telemedicine for new and existing patients without conducting a prior in-person medical evaluation through 2024.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

DEA officially extends remote EPCS flexibilities for 6 months

Healthcare IT News - Telehealth

This week, the DEA added some specificity to that promise – allowing an extension of six months, through November 11, 2023, and, in tandem with HHS' Substance Abuse and Mental Health Services Administration, promising a grace period for virtual prescribing of certain controlled medications to last at least until November 2024.

article thumbnail

DEA & SAMHSA Issue Temporary Rule Extending COVID-19 Telemedicine Flexibilities for Controlled Substances Prescribing Beyond the Termination of COVID-19 PHE

Hall Render

As a result, if a patient and a practitioner have appropriately established a telemedicine relationship on or before November 11, 2023, the same telemedicine flexibilities that have governed the relationship to that point will continue to be permitted until November 11, 2024.

article thumbnail

Medicare Physician Fee Schedule for 2023: What Providers Need to Know

Hall Render

Longstanding CMS policy has been that, for split or shared visits in an institutional setting, the physician can bill for the services if he/she performs a substantive portion of the encounter. CMS has chosen to extend its phase-in approach of defining “substantive portion” as more than half the time of the visit to CY 2024.

article thumbnail

Bonus Features – February 11, 2024 – HTI-1 final rule goes into effect March 11, Best in KLAS highlights 136 products in 8 categories, plus 28 more stories

Healthcare IT Today

News The 2024 Best in KLAS have been named. market, covered in the Software and Services report, KLAS recognized 136 software products across 8 categories. For the U.S. The Global Software report recognized regional leaders in acute care EHR and PACS.

article thumbnail

Five Opportunities to Use the Law to Address Persistent OUD Treatment Gaps 

Bill of Health

The nation’s experience with COVID-19 demonstrated the need for increased telemedicine options for the treatment of substance use, especially in suburban and rural areas where health provider closures may severely limit access to care.